Publications

The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine

ANZDATA
Article
  • Posted18 Jan 2017
  • PMID28109543

AuthorsLim, W, Russ GR, Wong G, Pilmore H, Kanellis, J, Chadban, S

Periodical/sKidney International